 |
(N-[2,6-bis(1-methylethyl)-pheyl-N’-[[1-4-dimethyl-amino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt |
|---|---|
| Trade Name | |
| Orphan Indication | Adrenocortical carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-03-09 00:00:00 |
| Sponsor | Millendo Therapeutics, Inc.;301 North Main Street, Suite 100;Ann Arbor, Michigan, 48104 |
